Perforated tissue matrix
US-2024408277-A1 · Dec 12, 2024 · US
US9327056B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9327056-B2 |
| Application number | US-67500607-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 14, 2007 |
| Priority date | Feb 14, 2006 |
| Publication date | May 3, 2016 |
| Grant date | May 3, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are devices for bone tissue engineering, comprising a metal or metal-based composite member comprising an interior macroporous structure with porosity varying from 0-90% (v), the member comprising a surface region having a surface pore size, porosity, and composition designed to encourage cell growth and adhesion thereon, to provide a device engineered for a particular recipient subject. Engineered devices may further comprises a gradient of pore size, porosity, and material composition extending from the surface region throughout the interior of the device, wherein the gradient transition is continuous, discontinuous or seamless to promote cell in-growth. Additional aspects provide methods for bone tissue engineering, comprising use of a metal or metal-based composite member comprising an interior porous structure, wherein the pore size, porosity and material composition is selected to provide a device having an optimal density and/or elastic modulus and/or compression strength for a specific recipient. Fabrication methods are provided.
Opening claim text (preview).
The invention claimed is: 1. A device for bone tissue engineering, comprising a member of a biocompatible metal or metal-based composite, the member having an exterior surface, an interior voided core area of void fraction between 30 and 90% by volume, and a porous exterior surface region configured to encourage cell growth and adhesion thereon, wherein an increasing porosity vol % gradient extends from the exterior surface, through the porous exterior surface region, and throughout the interior voided core area, and wherein at least one of the pore size, porosity and material composition is configured to provide a device having a target density, elastic modulus or compression strength for a specific recipient to provide an implantable device suitable for bone tissue engineering in a recipient subject. 2. The device of claim 1 , wherein gradients of pore size, porosity, and material composition extend from the porous exterior surface region into or throughout the interior voided core area of the device, and wherein transitions of the gradients are continuous or seamless. 3. The device of claim 1 , wherein the member comprises at least one material selected from the group consisting of titanium (Ti); commercially pure Ti; alpha Ti alloys; beta Ti alloys; aluminum (Al); iron (Fe); vanadium (V); Ti alloys and their intermetallics with major alloying elements including Al, V, Nb, Fe, Zr, Mo, O, Ni, Cr, Co, Ta, forming alloys including Ti6Al4V, Ti-6Al-7Nb, Ti-5Al-2.5Fe, Ti-12Mo-6Zr-2Fe, Ti-15Mo-5Zr-3Al, Ti-15Mo-3Nb-3O, Ti-13Nb-13Zr, Ti-35Nb-5Ta-7Zr; Stainless steel; CoCrMO; ceramics; metal oxides including TiO2; calcium based inorganic salt including calcium phosphates, calcium carbonates; silver and silver oxides; gold; and combinations thereof. 4. The device of any one of claims 1 - 3 , wherein the member or a portion of the porous exterior surface region thereof comprises a material composition of metal and ceramic in a continuous or seamless gradient from a position on the porous exterior surface region having a highest ceramic content, transitioning to lowest or zero ceramic content at an interior structure position composed of metal or metal-based composite. 5. The device of claim 4 , wherein the ceramic comprises an inorganic salt. 6. The device of claim 5 , wherein the inorganic salt comprises a form of calcium selected from the group consisting of calcium phosphates and calcium carbonates, and combinations thereof. 7. The device of any one of claims 1 - 3 , wherein the porous exterior surface region comprises nanoscale or microscale pores ranging from 1 nm to 500 nm in diameter, or from 1 nm to 1 μm. 8. The device of any one of claims 1 - 3 , wherein the interior voided core area comprises a microporous or macroporous pattern having pore sizes in the range of 1 μm to about 5 mm. 9. The device of any one of claims 1 - 3 , further comprising a chemical or biological agent deposited in or on the member or in one or more pores thereof to operatively provide for release or controlled release of the agent within a recipient. 10. The device of claim 9 , wherein the chemical or biological agent is deposited in or on one or more surface structures or pores thereof. 11. The device of claim 9 , wherein the agent comprises at least one agent suitable to provide a beneficial biological or physiological effect. 12. The device of claim 11 , wherein the at least one agent suitable to provide a beneficial biological or physiological effect comprises an antimicrobial agent. 13. The device of claim 11 , wherein the agent comprises at least one agent selected from the group consisting of antibiotics, growth factors, and drugs. 14. A recipient-optimized device for bone tissue engineering, comprising a member of a biocompatible metal or metal-based composite, the member having an exterior surface, an interior voided core area of void fraction between 30 and 90% by volume, and a porous exterior surface region, wherein an increasing porosity vol % gradient extends from the exterior surface, through the porous exterior surface region, and throughout the interior voided core area, and wherein at least one of the pore size, porosity and material composition is configured to provide a device having a target density for a specific recipient. 15. A recipient-optimized device for bone tissue engineering, comprising a member of a biocompatible metal or metal-based composite, the member having an exterior surface, an interior voided core area of void fraction between 30 and 90% by volume, and a porous exterior surface region, wherein an increasing porosity vol % gradient extends from the exterior surface, through the porous exterior surface region, and throughout the interior voided core area, and wherein at least one of the pore size, porosity and material composition is selected to provide a device having a target elastic modulus for a specific recipient. 16. A recipient-optimized device for bone tissue engineering, comprising a member of a biocompatible metal or metal-based composite, the member having an exterior surface, an interior voided core area of void fraction between 30 and 90% by volume, and a porous exterior surface region, wherein an increasing porosity vol % gradient extends from the exterior surface, through the porous exterior surface region, and throughout the interior voided core area, and wherein at least one of the pore size, porosity and material composition is selected to provide a device having a target compression strength for a specific recipient. 17. A device for bone tissue engineering, comprising: a member of a biocompatible metal or metal-based composite, the member having: an interior voided core area of void fraction between 30 and 90% by volume; and a porous exterior surface region configured to encourage cell growth and adhesion thereon, wherein an increasing porosity vol % gradient extends from the porous exterior surface region into the interior voided core area; and wherein the member or a portion of the porous exterior surface region thereof comprises a material composition of metal and ceramic in a continuous or seamless gradient from a position on the porous exterior surface region having a highest ceramic content, transitioning to lowest or zero ceramic content at an interior structure position composed of metal or metal-based composite. 18. The device of claim 17 , wherein the member comprises at least one material selected from the group consisting of: titanium (Ti); commercially pure Ti; alpha Ti alloys; beta Ti alloys; aluminum (Al); iron (Fe); vanadium (V); Ti alloys and their intermetallics with major alloying elements including Al, V, Nb, Fe, Zr, Mo, O, Ni, Cr, Co, Ta, forming alloys including Ti6Al4V, Ti-6Al-7Nb, Ti-5Al-2.5Fe, Ti-12Mo-6Zr-2Fe, Ti-15Mo-5Zr-3Al, Ti-15Mo-3Nb-3O, Ti-13Nb-13Zr, Ti-35Nb-5Ta-7Zr; Stainless steel; CoCrMO; ceramics; metal oxides including TiO2; calcium based inorganic salt including calcium phosphates, calcium carbonates; silver and silver oxides; gold; and combinations thereof. 19. The device of claim 18 , wherein the ceramic comprises an inorganic salt. 20. The device of claim 19 , wherein the inorganic salt comprises a form of calcium selected from the group consisting of calcium phosphates and calcium carbonates, and combinations thereof. 21. The device of claim 17 , wherein the porous exterior surface region comprises nanoscale or microscale pores ranging from 1 nm to 500 nm in diameter, or from 1 nm to 1 μm. 22. The device claim 17 , wherein the
X-shaped · CPC title
Silver or Ag-based alloys · CPC title
Supplementary information concerning processes or compositions relating to powder metallurgy · CPC title
Sets comprising a plurality of prosthetic parts of different sizes or orientations · CPC title
Titanium or titanium-based alloys, e.g. Ti-Ni alloys · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.